Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease

European Journal of Haematology

Volumn 84, Issue 3, 2010, Pages 259-265

  Mirre, Elsa ^a   Brousse, Valentine ^a   Berteloot, Laureline ^a   Lambot Juhan, Karen ^a   Verlhac, Suzanne ^b   Boulat, Claire ^a   Dumont, Marie Dominique ^a   Lenoir, Gérard ^a   De Montalembert, Mariane ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Sickle cell disease; Stroke; Transcranial Doppler; Transfusion

Indexed keywords

ERYTHROCYTE ANTIBODY; HEMOGLOBIN S; IRON;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CEREBROVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; IRON CHELATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SCHOOL CHILD; SICKLE CELL ANEMIA; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 76249102233     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01379.x     Document Type: Article

References (21)

1. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998 91 : 288 294.
2. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease; present and future. Lancet Neurol 2006 5 : 501 512.
3. Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, Olivieri N, Vichinsky E, Wang W, Brambilla D. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995 126 : 896 899.
4. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess D. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992 326 : 605 610.
5. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998 339 : 5 11.
6. Adams RJ, Brambilla D, Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005 353 : 2769 2778.
7. National Institutes of Health. The Management of Sickle Cell Disease, 4th edn. Originally Printed 1984. Revised June 2002. Bethesda : NIH Publication N°02-2117, 2002.
8. Riddington C, Wang W. Blood transfusion for preventing stroke in people with sickle cell disease. Cochrane Database Syst Rev 2002 Issue 1:CD003146.
9. Haute Autorité de Santé. Prise en charge de la drépanocytose chez l'enfant et l'adolescent. http://www.has-sante.fr/ portail/jcms/c-272479.
10. Bernaudin F, Verlhac S, Coïc L, Lesprit E, Brugières P, Reinert P. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol 2005 35 : 242 248.
11. Verlhac S. Doppler transcrânien et protocole de prévention des accidents vasculaires cérébraux de l'enfant drépanocytaire. Arch Pediatr 2008 15 : 636 638.
12. Vichinsky E, Onyekwere O, Porter J, et al. A randomised comparison of deferasirox versus deferoxamine in the treatment of transfusional iron overload in sickle cell disease. Br J Haematol 2007 136 : 501 508.
13. Aygun B, McMurray MA, Schultz WH, et al. Chronic transfusion practice for children with sickle cell anaemia and stroke. Br J Haematol 2009 145 : 524 528.
14. Vichinsky EP, Earles A, Johnson RA, Hoag M, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990 322 : 1617 1621.
15. Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Serjeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001 113 : 661 665.
16. Gulbis B, Haberman D, Dufour D, et al. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events, the Belgian experience. Blood 2005 105 : 2685 2690.
17. Cohen AR, Martin MB, Silber JH, Kim HC, Ohene-Frempong K, Schwartz E. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992 79 : 1657 1661.
18. Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion for at least five years after initial stroke. J Pediatr 2002 140 : 348 354.
19. Brousse V, Hertz-Pannier L, Consigny Y, Bresson JL, Girot R, Mirre E, Lenoir G, de Montalembert M. Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease? Ann Hematol 2009 88 : 785 788.
20. Wayne AS, Schoenike SE, Pegelow CH. Financial analysis of chronic transfusion for stroke prevention in sickle cell disease. Blood 2000 96 : 2369 2372.
21. Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell disease using hydroxyurea and phlebotomy. J Pediatr 2004 145 : 346 352.